196
Participants
Start Date
December 14, 2017
Primary Completion Date
November 7, 2018
Study Completion Date
November 7, 2018
Placebo
"Suspension administered orally for a treatment period of eight weeks (4 weeks of dose adjustment, 4 weeks in stable dose) .~Single dose contains from 1 to 3 sachets of Placebo depending on dose level assigned to a patient per non-dialysis days."
Sodium Zirconium Cyclosilicate (ZS)
"Suspension administered orally for a treatment period of eight weeks (4 weeks of dose adjustment, 4 weeks in stable dose) .~Single dose contains from 1 to 3 sachets of ZS 5g depending on dose level assigned to a patient per non-dialysis days."
Research Site, The Bronx
Research Site, Great Neck
Research Site, Fresh Meadows
Research Site, Ridgewood
Research Site, St Louis
Research Site, Kansas City
Research Site, Houston
Research Site, El Paso
Research Site, Los Angeles
Research Site, Los Angeles
Research Site, Whittier
Research Site, Ontario
Research Site, San Dimas
Research Site, Moscow
Research Site, Yaroslavl
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Rostov-on-Don
Research Site, Penza
Research Site, Yekaterinburg
Research Site, Novosibirsk
Research Site, Omsk
Research Site, Kemerovo
Research Site, Paterson
Research Site, East Providence
Research Site, Hamamatsu
Research Site, Kumamoto
Research Site, Miyagi-gun
Research Site, Nagano
Research Site, Niigata
Research Site, Ora-gun
Research Site, Osaka
Research Site, Sakaishi
Research Site, Sashima-gun
Research Site, Sendai
Research Site, Shinjuku-ku
Research Site, Toride-shi
Research Site, Tsukuba
Research Site, Wakayama
Research Site, Yachiyo-shi
Research Site, Yokosuka-shi
Research Site, Kolomna
Research Site, Podolsk
Research Site, Cardiff
Research Site, Hull
Research Site, Leicester
Research Site, London
Research Site, London
Research Site, London
Research Site, London
Research Site, Swansea
Research Site, York
Lead Sponsor
AstraZeneca
INDUSTRY